Soleno Therapeutics (SLNO) Interest Coverage Ratio (2013 - 2026)

Soleno Therapeutics (SLNO) reported Interest Coverage Ratio of 24.21 for Q1 2026, up 172.03% year-over-year from 8.9 in Q1 2025, and down 17.48% quarter-over-quarter from 29.34 in Q4 2025.

Soleno Therapeutics (SLNO) Interest Coverage Ratio (2013 - 2026) Analysis & Trends

Soleno Therapeutics (SLNO) has 5 years of Interest Coverage Ratio data on file, last reported at 24.21 in Q1 2026.

  • Interest Coverage Ratio for Q1 2026 came in at 24.21, up 172.03% year-over-year; the trailing twelve-month figure through Mar 2026 was 15.99 (up 110.36% YoY), and the FY2025 annual result was 1.72, up 100.21% from the prior year.
  • Interest Coverage Ratio retreated to 24.21 in Q1 2026 per SLNO's latest filing, from 29.34 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 29.34 in Q4 2025 and troughed at 33.61 in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 3.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 11.50
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -258.33
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 547.67
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 11.79
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn 24.21

Historic Data

Download Data
DateValue
Mar 31, 2026 24.21
Dec 31, 2025 29.34
Sep 30, 2025 15.90
Jun 30, 2025 -4.74
Mar 31, 2025 -33.61
Dec 31, 2015 3,506.75
Mar 31, 2015 -2,426.00
Dec 31, 2014 -0.80
Sep 30, 2014 -1.76
Jun 30, 2014 -1.95
Mar 31, 2014 -1.76
Dec 31, 2013 -1.80
Sep 30, 2013 -1.74